Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Short-Term Debt issuances (2024 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Short-Term Debt issuances for 2 consecutive years, with $11.2 million as the latest value for Q4 2025.

  • Quarterly Short-Term Debt issuances rose 100.95% to $11.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.8 million through Dec 2025, up 200.95% year-over-year, with the annual reading at $60.1 million for FY2025, 376.66% up from the prior year.
  • Short-Term Debt issuances for Q4 2025 was $11.2 million at Nuvation Bio, up from $5.6 million in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $11.2 million in Q4 2025, with the low at $5.6 million in Q4 2024.